Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Avadel Pharmaceuticals plc (AVDL)

1.46   0.12 (8.96%) 05-21 16:00
Open: 1.35 Pre. Close: 1.34
High: 1.49 Low: 1.35
Volume: 437,506 Market Cap: 55M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.492 - 1.498 1.498 - 1.503
Low: 1.336 - 1.342 1.342 - 1.349
Close: 1.449 - 1.459 1.459 - 1.47

Technical analysis

as of: 2019-05-21 4:25:16 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.74     One year: 2.03
Support: Support1: 1.21    Support2: 1.03
Resistance: Resistance1: 1.49    Resistance2: 1.74
Pivot: 1.27
Moving Average: MA(5): 1.34     MA(20): 1.23
MA(100): 1.91     MA(250): 3.70
MACD: MACD(12,26):     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 81.11     %D(3): 73.43
RSI: RSI(14): 60.64
52-week: High: 7.97  Low: 1.03  Change(%): -78.2
Average Vol(K): 3-Month: 20069  10-Days: 24801

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AVDL has closed above the upper band by 12.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 61.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to AVDL's normal range. The bands have been in this narrow range for 33 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 27 Mar 2019 22:07:15 Z
Jazz's Xyrem Follow-On Drug Succeeds in Phase III Study

Wed, 20 Mar 2019 17:09:24 Z
Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision

Fri, 04 Jan 2019 19:08:33 Z
Mid-Day Market Update: Resources Connection Rises Following Q2 Results; Arcus Biosciences Shares Slide

Mon, 24 Dec 2018 17:11:46 Z
Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA

Thu, 28 Jun 2018 17:09:58 Z
Jazz Pharmaceuticals' sNDA for Xyrem Gets Priority Review

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37.36
Shares Float (M) 36.07
% Held by Insiders
% Held by Institutions 63.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -2.000
EPS Est. Current Year 1.160
EPS Est. Next Year 0.250
EPS Est. Next Quarter -0.100
Forward EPS -0.060
Book Value (p.s.) 15.590
PEG Ratio 0.15
Profit Margin
Operating Margin -64.64
Return on Assets (ttm) -38.9
Return on Equity (ttm) -275.7
Qtrly Rev. Growth -50.6
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -85.91
Levered Free Cash Flow (M) -90.76

Stock Valuations

P/E -0.73
P/E Growth Ratio 0.09
P/BV 0.09
P/S 23410128.00
P/CF -0.63

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.